Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone

CONCLUSIONS: It is recommended that clinicians monitor the diffusion capacity of carbon monoxide and lung ventilation function of patients before and after using dronedarone for treatment. For patients with a history of amiodarone exposure, intermittent monitoring of chest X-rays and lung function is necessary. If lung function decreases, dronedarone should be immediately discontinued.PMID:38617895 | PMC:PMC11015333 | DOI:10.1016/j.curtheres.2024.100743
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research